M. Cera

发表

Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation

A. Colombo, E. Agricola, G. Fragasso, 2016, International journal of cardiology. Heart & vasculature.

[Cardiac stem cell therapy for the treatment of chronic stable angina refractory to conventional therapy. State of the art and current clinical experience of the San Raffaele Hospital of Milan, Italy].

G. Condorelli, L. Gianolli, M. Capogrossi, 2011, Giornale italiano di cardiologia.

Platelet reactivity in response to loading dose of atorvastatin or rosuvastatin in patients with stable coronary disease before percutaneous coronary intervention: The STATIPLAT randomized study

A. Colombo, A. Mangieri, A. Chieffo, 2017, Clinical cardiology.

Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease.

O. Alfieri, A. Colombo, C. Campochiaro, 2017, American journal of cardiovascular disease.

Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study

M. Neary, A. Colao, P. Thompson-Leduc, 2019, Journal of Endocrinological Investigation.

Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry)

A. Colombo, G. Sangiorgi, G. Parodi, 2010 .

Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry).

E. Romagnoli, C. Di Mario, A. Colombo, 2008, The American journal of cardiology.

Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation.

A. Margonato, C. Pivato, C. Godino, 2020, The American journal of cardiology.

Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?

A. Maseri, A. Colombo, A. Chieffo, 2009, Thrombosis journal.

Baseline Characteristics and 3-Year Outcome of Nonvalvular Atrial Fibrillation Patients Treated with the Four Direct Oral Anticoagulants (DOACs).

M. Tresoldi, A. Margonato, P. Della Bella, 2023, American Journal of Cardiology.

Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight

O. Alfieri, M. Filippi, A. Zangrillo, 2021, European journal of clinical investigation.

Real-world 2-year outcome of atrial fibrillation treatment with dabigatran, apixaban, and rivaroxaban in patients with and without chronic kidney disease

A. Colombo, A. Margonato, P. Della Bella, 2019, Internal and Emergency Medicine.

Inappropriate dose of nonvitamin-K antagonist oral anticoagulants: prevalence and impact on clinical outcome in patients with nonvalvular atrial fibrillation.

O. Alfieri, A. Zangrillo, M. Tresoldi, 2020, Journal of cardiovascular medicine.

Role of Metabolic Modulation in the Management of chronic Ischemic Heart Disease

G. Fragasso, A. Margonato, C. Torlasco, 2010 .

Prognostic role of stress/rest myocardial perfusion scintigraphy in patients with cardiac syndrome x.

L. Gianolli, A. Colombo, P. Todeschini, 2014, International journal of cardiology.

Beneficial Electrophysiological Effects of Trimetazidine in Patients With Postischemic Chronic Heart Failure

G. Fragasso, A. Margonato, R. Spoladore, 2010, Journal of cardiovascular pharmacology and therapeutics.

Coronary reactivity testing in vasospastic angina leading to cardiac arrest and coronary dissection.

F. Pappalardo, F. Giannini, M. Oppizzi, 2016, International journal of cardiology.